Project HybrAid – Hybrid solution for enhanced vision-aid for blind people by pharmaceuticals and high-conductive…

Basic data

Acronym:
HybrAid
Title:
Hybrid solution for enhanced vision-aid for blind people by pharmaceuticals and high-conductive electrical electrodes.
Duration:
01/09/2018 to 31/12/2020
Abstract / short description:
To date, no potent therapeutic aid is available to prevent or cure blindness. Hence, the proposed study, HybrAid, aims to evolve a novel proof of concept for enhanced vision-aid for blind people, synergising the best of two worlds: The potential of neuroprotective drugs and the efficacy of high-conductive electrodes for electrical stimulation.
Keywords:
hereditary retinal diseases
erbliche Netzhauterkrankungen
vision rescue

Involved staff

Managers

Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Research Center for Ophthalmology
Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Tübingen, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.